We evaluated 54 children – 24 children with inflammatory bowel disease, 15 with other non-infectious intestinal diseases and 15 healthy controls. All of the children provided fresh fecal samples for measurement of Fecal Calprotectin (FC). FC concentration was assayed by two methods – quantitative point of care test and ELISA test. The mean FC levels were significantly increased in all of the patients with intestinal inflammation. There was a strong correlation between the results obtained from the point of care test and the ELISA assay. FC point of care testing is a useful non-invasive screening tool in the pediatric practice.

 

Download Full Text - PDF